scholarly journals A Hybrid Fuzzy TOPSIS Method to Analyze the Coverage of a Hypothetical EU Ecolabel for Fishery and Aquaculture Products (FAPs)

2020 ◽  
Vol 11 (1) ◽  
pp. 112
Author(s):  
Javier Cantillo ◽  
Juan Carlos Martín ◽  
Concepción Román
Keyword(s):  
Ethical Issues ◽  
Environmental Issues ◽  
Analysis Data ◽  
Public Consultation ◽  
Topsis Method ◽  
Social And Ethical Issues ◽  
Aquaculture Products ◽  
Types Of Information ◽  
The Eu ◽  
Eu Ecolabel

This study presents a hybrid fuzzy technique for order preference by similarity of the ideal solution (TOPSIS) method (FTOPSIS) to analyze the coverage of a hypothetical EU ecolabel for fishery and aquaculture products (FAPs) by integrating a synthetic indicator to determine the level of acceptance for the inclusion of different types of information apart from environmental issues, considering different stakeholders and other segments of analysis. Data were obtained from a public consultation of the EU on “ecolabels for FAPs”. The results indicate that ecolabels should not only include environmental issues but also other types of information, with social and ethical issues being the most relevant, followed by animal welfare issues, health and safety issues and food quality issues. The findings also show that consumers, producers and stakeholders who are more interventionist and support the fact that public bodies and governments should be involved in the control of eco-labeling are more accepting of including additional information apart from environmental issues. Synthetic indicators (SIs) have also been found to be mostly inelastic, except for the owners of ecolabels on social and ethical issues. The implications of the future implementation of the EU ecolabel for FAPs are discussed based on the findings.

Organizational and patient-related assessments in HTAs: State of the art

2009 ◽  
Vol 25 (4) ◽  
pp. 530-536 ◽  
Author(s):  
Anne Lee ◽  
Line Sinding Skött ◽  
Helle Ploug Hansen
Keyword(s):  
Qualitative Analysis ◽  
Patient Information ◽  
Web Sites ◽  
Ethical Issues ◽  
State Of The Art ◽  
Environmental Issues ◽  
Organizational Structures ◽  
Psychological Issues ◽  
Health Technologies ◽  
Social And Ethical Issues

Objectives: The use and implementation of health technologies do influence and are influenced by organizational structures and processes as well as patient's experiences and actions. The objective of this study is to discuss the content and managing of organizational and patient-related assessments in HTAs.Methods: Quantitative and qualitative analysis were performed based on a review of organizational and patient-related assessments included in a random sample of fifty HTA reports. The reports were identified from INAHTA members’ Web sites where homepages of HTA agencies where searched for full HTA reports, published in English or Scandinavian languages.Results: HTA reports including organizational assessments mainly comprised issues related to process and structure, while issues such as control and evaluation of the technology were included less often. Cultural and environmental issues were included in a little over half of the reports. Reports including patient-related assessments mainly comprised psychological issues. Patients’ perceptions of the technology's effect on their health, patient-information, and social and ethical issues were included less often. Few reports included implications for the patient's significant others. There was considerable variation in how comprehensive the issues were managed as there was in the methodological transparency of the HTA reports.Conclusions: There is room for improvement in the assessments of organizational and patient-related issues. Absence of a description of the considerations made when determining the content and methods of the assessments limits the usefulness of an HTA. The reader is left uncertain of the relevance and validity of the organizational and patient-related assessments.

Regulating Sustainability Claims on Seafood - EU Ecolabel, Unfair Commercial Practices Directive or Seafood Information Requirements?

2016 ◽  
Vol 7 (4) ◽  
pp. 784-788 ◽  
Author(s):  
Hanna Schebesta
Keyword(s):  
European Commission ◽  
Policy Option ◽  
Information Requirements ◽  
Strong Case ◽  
Seafood Products ◽  
The Common ◽  
Aquaculture Products ◽  
Unfair Commercial Practices Directive ◽  
The Eu ◽  
Eu Ecolabel

AbstractIn February 2016, the Feasibility Report on options for an EU ecolabel scheme for fishery and aquaculture products was published. The study did not make a strong case for the introduction of a seafood EU Ecolabel and it is unlikely that the European Commission will pursue this policy option. We argue that sustainability information on seafood should not be framed through the EU Ecolabel debate. The more pressing issue concerns self-declared sustainability claims on seafood products. As a possible solution, we propose to address these by re-invigorating the labelling rules on seafood information in the Regulation on the Common Organisation of the Markets in Fishery and Aquaculture Products.

Using information technology to integrate social and ethical issues into the computer science and information systems curriculum

1997 ◽  
Vol 25 (4) ◽  
pp. 38-47 ◽  
Author(s):  
Mary J. Granger ◽  
Elizabeth S. Adams ◽  
Christina Björkman ◽  
Don Gotterbarn ◽  
Diana D. Juettner ◽  
...  
Keyword(s):  
Information Technology ◽  
Information Systems ◽  
Computer Science ◽  
Ethical Issues ◽  
Social And Ethical Issues ◽  
Information Systems Curriculum

Conferring a Federal Property Right in Genetic Material: Stepping into the Future with the Genetic Privacy Act

1996 ◽  
Vol 22 (1) ◽  
pp. 109-134
Author(s):  
Michael M.J. Lin
Keyword(s):  
Ethical Issues ◽  
Raw Materials ◽  
Genetic Diseases ◽  
Genetic Material ◽  
Genetic Privacy ◽  
Genetic Characteristics ◽  
Dna Evidence ◽  
Privacy Act ◽  
National Rule ◽  
Social And Ethical Issues

“A wise man can hear profit in the wind.”—Pel, quoting the Ferengi Rules of AcquisitionThe expansive biotechnology field includes many facets of medical research, from drug discovery and design, to gene therapy and the diagnosis of genetic diseases, to the use of deoxyribonucleic acid (DNA) evidence to identify individuals and genetic characteristics. The biotechnology industry requires a readily available supply of biological raw materials; much of current research is founded on cells, tissues, organs, fetal tissues and placentas, and other samples derived from human donors. However, this growing need for raw materials presents many economic, social, and ethical issues to society, researchers, and the existing legal regime. Furthermore, because courts and legislatures fail to provide a clear national rule regarding biological materials, the resulting legal uncertainties chill research and investment. Although very few cases address property rights in a person’s organs, tissues, and genetic material, the issues of autonomy and privacy involved evoke analogies to deep-seated issues such as slavery, the freezing of embryos, and abortion.

Kleine deeltjes, grote kwesties

2013 ◽  
Vol 41 (2) ◽  
Author(s):  
Lucien Hanssen ◽  
Tim Vos ◽  
Maartje Langeslag ◽  
Bart Walhout
Keyword(s):  
Civil Society ◽  
Ethical Issues ◽  
Civil Society Organizations ◽  
Small Particles ◽  
Academic Organizations ◽  
Civil Society Organisations ◽  
National Debate ◽  
Wide Range ◽  
Social And Ethical Issues ◽  
Issue Analysis

Small particles, big issues. An issue analysis of the Dutch national dialogue nanotechnology Small particles, big issues. An issue analysis of the Dutch national dialogue nanotechnology In 2010 the Dutch government sponsored a national dialogue on nanotechnology. A wide range of activities was organised to bring scientific and societal views into this national debate. Issue analysis showed that risk issues concerning health and environment got most attention. Good legislation and ethical motives also came up as prominent topics in discussions. Next to issue analysis, we analysed the type of organizations that orchestrated the different projects and we looked at possibilities to bring in public voices. It turned out that there is no difference in public outreach or involvement among professional media, civil society, or academic organizations. Civil society organizations often set social and ethical issues on the agenda. Due to a lack of capacity and expertise their actual participation in dialogue projects was limited. To strengthen a more robust societal perspective in further national dialogues one could invest in capacity building for civil society organisations.

scholarly journals A Healthy Sense of Trust

2017 ◽  
Vol 2 (Suppl. 1) ◽  
pp. 1-10
Author(s):  
Denis Horgan
Keyword(s):  
European Union ◽  
Clinical Trials ◽  
Big Data ◽  
Data Protection ◽  
Fast Moving ◽  
Ethical Issues ◽  
Personalised Medicine ◽  
Drug Pricing ◽  
The Right ◽  
The Eu

In the fast-moving arena of modern healthcare with its cutting-edge science it is already, and will become more, vital that stakeholders collaborate openly and effectively. Transparency, especially on drug pricing, is of paramount importance. There is also a need to ensure that regulations and legislation covering, for example the new, smaller clinical trials required to make personalised medicine work effectively, and the huge practical and ethical issues surrounding Big Data and data protection, are common, understood and enforced across the EU. With more integration, collaboration, dialogue and increased trust among each and every one in the field, stakeholders can help mould the right frameworks, in the right place, at the right time. Once achieved, this will allow us all to work more quickly and more effectively towards creating a healthier - and thus wealthier - European Union.

Sign in / Sign up

Export Citation Format

Share Document